207 related articles for article (PubMed ID: 29636345)
1. Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8
Johnson CB; May BR; Riesenberg BP; Suriano S; Mehrotra S; Garrett-Mayer E; Salem ML; Jeng EK; Wong HC; Paulos CM; Wrangle JM; Cole DJ; Rubinstein MP
Cancer Res; 2018 Jun; 78(11):3067-3074. PubMed ID: 29636345
[TBL] [Abstract][Full Text] [Related]
2. Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent.
Johnson CB; Riesenberg BP; May BR; Gilreath SC; Li G; Staveley-O'Carroll KF; Garrett-Mayer E; Mehrotra S; Cole DJ; Rubinstein MP
Cancer Immunol Res; 2015 Dec; 3(12):1364-74. PubMed ID: 26297711
[TBL] [Abstract][Full Text] [Related]
3. Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion.
Ng SSM; Nagy BA; Jensen SM; Hu X; Alicea C; Fox BA; Felber BK; Bergamaschi C; Pavlakis GN
Clin Cancer Res; 2017 Jun; 23(11):2817-2830. PubMed ID: 27986749
[No Abstract] [Full Text] [Related]
4. Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.
Tanaka T; Watanabe S; Takahashi M; Sato K; Saida Y; Baba J; Arita M; Sato M; Ohtsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Aoki N; Ohshima Y; Sakagami T; Abe T; Moro H; Koya T; Tanaka J; Kagamu H; Yoshizawa H; Kikuchi T
PLoS One; 2017; 12(8):e0183976. PubMed ID: 28854279
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.
Bowers JS; Nelson MH; Kundimi S; Bailey SR; Huff LW; Schwartz KM; Cole DJ; Rubinstein MP; Paulos CM
Clin Cancer Res; 2015 Jun; 21(11):2546-57. PubMed ID: 25904754
[TBL] [Abstract][Full Text] [Related]
6. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.
Gattinoni L; Finkelstein SE; Klebanoff CA; Antony PA; Palmer DC; Spiess PJ; Hwang LN; Yu Z; Wrzesinski C; Heimann DM; Surh CD; Rosenberg SA; Restifo NP
J Exp Med; 2005 Oct; 202(7):907-12. PubMed ID: 16203864
[TBL] [Abstract][Full Text] [Related]
7. PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Takahashi M; Watanabe S; Suzuki R; Arita M; Sato K; Sato M; Sekiya Y; Abe Y; Fujisaki T; Ohtsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Saida Y; Hokari S; Aoki N; Hayashi M; Ohshima Y; Koya T; Kikuchi T
Cancer Immunol Immunother; 2022 Jun; 71(6):1357-1369. PubMed ID: 34657194
[TBL] [Abstract][Full Text] [Related]
8. Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy.
Wang LX; Kjaergaard J; Cohen PA; Shu S; Plautz GE
J Immunol; 2004 Mar; 172(6):3462-8. PubMed ID: 15004146
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
Mueller K; Schweier O; Pircher H
Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
[TBL] [Abstract][Full Text] [Related]
10. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.
Paulos CM; Wrzesinski C; Kaiser A; Hinrichs CS; Chieppa M; Cassard L; Palmer DC; Boni A; Muranski P; Yu Z; Gattinoni L; Antony PA; Rosenberg SA; Restifo NP
J Clin Invest; 2007 Aug; 117(8):2197-204. PubMed ID: 17657310
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.
Wrzesinski C; Paulos CM; Gattinoni L; Palmer DC; Kaiser A; Yu Z; Rosenberg SA; Restifo NP
J Clin Invest; 2007 Feb; 117(2):492-501. PubMed ID: 17273561
[TBL] [Abstract][Full Text] [Related]
13. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells.
Wang LX; Shu S; Plautz GE
Cancer Res; 2005 Oct; 65(20):9547-54. PubMed ID: 16230420
[TBL] [Abstract][Full Text] [Related]
14. CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice.
Wang LX; Li Y; Yang G; Pang PY; Haley D; Walker EB; Urba WJ; Hu HM
Eur J Immunol; 2010 May; 40(5):1375-85. PubMed ID: 20186876
[TBL] [Abstract][Full Text] [Related]
15.
Hu X; Majchrzak K; Liu X; Wyatt MM; Spooner CJ; Moisan J; Zou W; Carter LL; Paulos CM
Cancer Res; 2018 Jul; 78(14):3888-3898. PubMed ID: 29769201
[TBL] [Abstract][Full Text] [Related]
16. Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
Saida Y; Watanabe S; Tanaka T; Baba J; Sato K; Shoji S; Igarashi N; Kondo R; Okajima M; Koshio J; Ichikawa K; Nozaki K; Ishikawa D; Koya T; Miura S; Tanaka J; Kagamu H; Yoshizawa H; Nakata K; Narita I
J Immunol; 2015 Jul; 195(2):726-35. PubMed ID: 26041539
[TBL] [Abstract][Full Text] [Related]
17. Effect of in vitroexpanded CD4(+)CD25(+)Foxp3(+) regulatory T cell therapy combined with lymphodepletion in murine skin allotransplantation.
Park YH; Koo SK; Kim Y; Kim HM; Joe IY; Park CS; Kim SC; Han DJ; Lim DG
Clin Immunol; 2010 Apr; 135(1):43-54. PubMed ID: 20006940
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.
Wang LX; Li R; Yang G; Lim M; O'Hara A; Chu Y; Fox BA; Restifo NP; Urba WJ; Hu HM
Cancer Res; 2005 Nov; 65(22):10569-77. PubMed ID: 16288050
[TBL] [Abstract][Full Text] [Related]
20. IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.
Yu EM; Cho E; Singh R; Kim SH; Han C; Han S; Lee DG; Kim YH; Kwon BS; Choi BK
Cells; 2021 Aug; 10(8):. PubMed ID: 34440787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
